Related Experiment Video
Updated: Sep 15, 2025

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
Published on: September 5, 2017
Tuberculosis in Turkiye: Epidemiological insights and recommendations for progress
Defne Yigci1, İlker Kayı2, Yusuf Ziya Demiroğlu3
1School of Medicine, Koc University, Istanbul, 34010, Turkey.
Tuberculosis incidence is declining in Turkey, but multidrug-resistant TB is rising. Addressing diagnostic delays and improving treatment adherence are crucial for better outcomes.
Area of Science:
- Public Health
- Epidemiology
- Infectious Diseases
Background:
- Tuberculosis (TB) presents a significant global public health challenge.
- This study offers an overview of TB epidemiology in Turkey.
- Key findings focus on TB incidence, diagnostic challenges, and treatment outcomes.
Purpose of the Study:
- To analyze current TB epidemiology in Turkey.
- To highlight challenges in TB diagnosis and treatment.
- To provide recommendations for reducing TB incidence and improving outcomes.
Main Methods:
- Epidemiological data analysis.
- Review of diagnostic challenges.
- Assessment of treatment outcomes.
Main Results:
- TB incidence in Turkey shows a gradual decline, with a rate of 11.5 per 100,000 in 2022.
- The prevalence of multidrug-resistant TB (MDR-TB) is increasing, especially in foreign-born populations.
- Delays in diagnosing extrapulmonary TB forms (e.g., TB meningitis, spondylodiscitis) impede effective treatment.
Conclusions:
- Critical gaps exist in diagnostic tools, treatment adherence, and healthcare worker knowledge.
- Recommendations include implementing rapid molecular diagnostics and strengthening policies for at-risk groups.
- Leveraging mobile health platforms can enhance treatment adherence monitoring.
More Related Videos
06:26Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis
Published on: July 28, 2023
10:29A High-throughput Compatible Assay to Evaluate Drug Efficacy against Macrophage Passaged Mycobacterium tuberculosis
Published on: March 24, 2017
Related Concept Videos
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Introduction to Epidemiology